The biopharma stock shot up more than 865% in 3 days before massive short interest dragged it down almost 50% on Tuesday, but will the Apes pounce?
The biopharma stock shot up more than 865% in 3 days before massive short interest dragged it down almost 50% on Tuesday, but will the Apes pounce?